$EYPT - Perfect Trend Retracement - Bulls Winning

2019年10月11日EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

SHORT INTEREST
5.18M 09/30/19

P/E Current
-1.93

P/E Ratio (with extraordinary items)
-2.86

Average Recommendation: BUY

Average Target Price: 5.13